Published in Arch Med Sci on July 04, 2012
D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure? Med Sci Monit (2015) 0.77
Concerted regulation of renal plasma flow and glomerular filtration rate by renal dopamine and NOS I in rats on high salt intake. Physiol Rep (2017) 0.75
Effect of nitric oxide pathway regulation on water/sodium balance and renal function in a rodent model of acute liver and renal failure. Med Sci Monit (2014) 0.75
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut (2011) 2.65
Nitric oxide in gastrointestinal health and disease. Gastroenterology (2004) 1.87
The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem (1993) 1.80
A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis. Hepatology (2005) 1.59
An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol (2009) 1.54
Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor. BMC Gastroenterol (2010) 1.49
Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension. Liver Int (2008) 1.46
Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol (1994) 1.44
Lipids, blood pressure, kidney - what was new in 2011? Arch Med Sci (2011) 1.37
Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med (1998) 1.36
Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase. J Am Soc Nephrol (2003) 1.21
Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat. Am J Physiol Renal Physiol (2004) 1.04
Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure. Gut (2002) 1.00
Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol (2011) 0.99
Complications and outcomes in chronic liver disease. Curr Opin Gastroenterol (2011) 0.96
Renal dysfunction as a consequence of acute liver damage by bile duct ligation in cirrhotic rats. Exp Toxicol Pathol (2006) 0.95
Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury. Med Sci Monit (2011) 0.93
The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function. JPEN J Parenter Enteral Nutr (2008) 0.92
Acute-on-chronic liver failure: the kidneys. Curr Opin Crit Care (2011) 0.91
Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis. Hepatology (1995) 0.90
Systemic and regional hemodynamics in pigs with acute liver failure and the effect of albumin dialysis. Scand J Gastroenterol (2006) 0.90
Clinical spectrum of renal disorders in patients with cirrhosis of liver. Ren Fail (2011) 0.89
Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat. Am J Physiol Regul Integr Comp Physiol (2006) 0.87
Hepatosplanchnic haemodynamics and renal blood flow and function in rats with liver failure. Gut (1998) 0.87
Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol (2010) 0.87
DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains. Am J Physiol Renal Physiol (2006) 0.87
Hepatorenal syndrome: a dreaded complication of end-stage liver disease. Am J Gastroenterol (2005) 0.86
Endothelin and nitric oxide in hepatorenal syndrome: a balance reset. J Nephrol (1997) 0.86
Hepatorenal syndrome. South Med J (2010) 0.85
Protective effect of decorin on acute ischaemia-reperfusion injury in the rat kidney. Arch Med Sci (2011) 0.85
Increased plasma nitric oxide, L-arginine, and arginase-1 in cirrhotic patients with progressive renal dysfunction. J Gastroenterol Hepatol (2009) 0.84
Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis. Hepatology (2008) 0.84
Interactive effects of endogenous morphine, nitric oxide, and ethanol on mitochondrial processes. Arch Med Sci (2010) 0.83
Bile duct ligation in rats: a reliable model of hepatorenal syndrome? World J Gastroenterol (2009) 0.83
Proinflammation and preconditioning protection are part of a common nitric oxide mediated process. Med Sci Monit (2010) 0.83
Decreased IgA+ plasma cells and IgA expression in acute liver necrosis mice. World J Gastroenterol (2010) 0.80
Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats. Liver Int (2005) 0.80
Terlipressin in hepatorenal syndrome. Ann Pharmacother (2011) 0.79
Management of refractory ascites and hepatorenal syndrome. Curr Gastroenterol Rep (2011) 0.79
Restrictive model of compensated carbon tetrachloride-induced cirrhosis in rats. World J Gastroenterol (2008) 0.79
Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension. Hepatobiliary Pancreat Dis Int (2008) 0.78
Extrapulmonary lymphangioleiomyomatosis presented as the asymptomatic retroperitoneal tumours--two cases report. Pol J Pathol (2006) 1.37
New automated image analysis method for the assessment of Ki-67 labeling index in meningiomas. Folia Histochem Cytobiol (2009) 1.07
Image processing for accurate cell recognition and count on histologic slides. Anal Quant Cytol Histol (2006) 1.03
Comparative analysis of methods for accurate recognition of cells through nuclei staining of Ki-67 in neuroblastoma and estrogen/progesterone status staining in breast cancer. Anal Quant Cytol Histol (2009) 1.02
Methods of central vascular access for haemodialysis. Anaesthesiol Intensive Ther (2013) 0.97
Renal vascular response to angiotensin II inhibition in intensive antihypertensive treatment of essential hypertension. Arch Med Sci (2010) 0.95
Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain. Breast Cancer Res (2012) 0.95
Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains. Arch Virol (2011) 0.93
Psychological aspects of dialysis: does cognitive appraisal determine the overall outcome? Pol Arch Med Wewn (2010) 0.93
Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system. Onco Targets Ther (2013) 0.89
Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in invasive breast cancer in women. Arch Med Sci (2012) 0.89
K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy. Cancer Biol Ther (2012) 0.89
Renal resistive index as a marker of vascular damage in cardiovascular diseases. Int Urol Nephrol (2014) 0.86
Accuracy of a remote quantitative image analysis in the whole slide images. Diagn Pathol (2011) 0.86
[Influence of controlled hypotensive therapy on renal autoregulation efficiency in the doppler captopril test in patients with chronic glomerulonephritis]. Pol Merkur Lekarski (2008) 0.83
Renal autoregulation in medical therapy of renovascular hypertension. Arch Med Sci (2010) 0.83
Surveillance of hantaviruses in Poland: a study of animal reservoirs and human hantavirus disease in Subcarpathia. Vector Borne Zoonotic Dis (2014) 0.83
Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment: case report. Pol Arch Med Wewn (2009) 0.82
Survivin expression as a prognostic factor in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy. Int J Gynecol Cancer (2014) 0.82
The kinetics of water transperitoneal transport during long-term peritoneal dialysis performed using icodextrin dialysis fluid. Pol Arch Med Wewn (2009) 0.82
[Role of nitric oxide system in pathogenesis of experimental model of hepatorenal syndrome]. Pol Merkur Lekarski (2008) 0.81
HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway. PLoS One (2013) 0.81
Albuminuria and hyperhomocysteinemia as cardiovascular risk factors in potentially healthy soldiers: A long-term observation. Med Sci Monit (2012) 0.80
Assessment of in vitro cellular responses of monocytes and keratinocytes to tannic acid modified silver nanoparticles. Toxicol In Vitro (2013) 0.80
Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment. Pol Arch Med Wewn (2009) 0.79
New aspects of the infection mechanisms of Bacillus anthracis. Ann Agric Environ Med (2012) 0.79
Diuretic-resistant congestive heart failure treated successfully with peritoneal ultrafiltration. Kardiol Pol (2013) 0.79
[Severe nephrotic syndrome requiring bilateral renal arteries embolisation in patient with membranous and diabetic nephropathy]. Pol Merkur Lekarski (2008) 0.79
Echocardiographic markers of left ventricular dysfunction among men with uncontrolled hypertension and stage 3 chronic kidney disease. Med Sci Monit (2013) 0.79
[Usefulness of ultrasonographic renal resistive index in monitoring efficacy of hypotensive in haemodialysed patients--case report]. Pol Merkur Lekarski (2002) 0.78
Insulin resistance as a novel therapeutic target in patients with chronic kidney disease treated with dialysis. Pol Arch Med Wewn (2010) 0.78
Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone. Arch Dermatol Res (2007) 0.77
[Advances in diagnosis and treatment of AL amyloidosis]. Pol Merkur Lekarski (2008) 0.77
Morphological evidence of the beneficial role of immune system cells in a rat model of surgical brain injury. Folia Neuropathol (2013) 0.77
Isolation and characterization of a novel bacteriophage φ4D lytic against Enterococcus faecalis strains. Curr Microbiol (2012) 0.76
[Histoclinic of "indeterminate colitis"]. Pol Merkur Lekarski (2007) 0.76
Synthetic immunostimulatory oligonucleotides in experimental and clinical practice. Pharmacol Rep (2012) 0.76
Acute kidney failure complicating carbon monoxide poisoning. Anaesthesiol Intensive Ther (2012) 0.76
[Evaluation of the number of enterochromaffin cells in gastric mucosa in subjects with functional dyspepsia]. Pol Merkur Lekarski (2009) 0.76
Mutations in the von hippel-lindau tumour suppressor gene in central nervous system hemangioblastomas. Hered Cancer Clin Pract (2004) 0.75
The effect of anti-inflammatory and antimicrobial herbal remedy PADMA 28 on immunological angiogenesis and granulocytes activity in mice. Mediators Inflamm (2013) 0.75
A case of a large solitary fibrous tumour of the uterine cervix. BMC Womens Health (2014) 0.75
Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy. Contemp Oncol (Pozn) (2012) 0.75
Biological agents database in the armed forces. Arch Immunol Ther Exp (Warsz) (2014) 0.75
[The rare case of nasal glioma]. Otolaryngol Pol (2005) 0.75
[Spiral computed tomography in evaluation of arteriovenous fistula for hemodialysis. Preliminary report]. Pol Merkur Lekarski (2002) 0.75
[Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis]. Pol Merkur Lekarski (2004) 0.75
[Mathematical analysis of the possibilities of automated peritoneal dialysis optimization]. Pol Merkur Lekarski (2002) 0.75
Research on substances with activity against orthopoxviruses. Ann Agric Environ Med (2013) 0.75
[Selected research problems of anthrax vaccine development]. Przegl Epidemiol (2009) 0.75
[Possibilities and limitations of morphological diagnosis in early stages of colitis]. Pol Merkur Lekarski (2004) 0.75
[Non-erosive reflux disease in endoscopy and histopathology]. Pol Merkur Lekarski (2009) 0.75
[Endoscopic polypectomy in colorectal cancer prophylaxis]. Pol Merkur Lekarski (2007) 0.75
[Thermal shrinkage of anterior cruciate ligament--if it works?]. Pol Merkur Lekarski (2014) 0.75
[Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome]. Pol Merkur Lekarski (2008) 0.75
[The possibilities and barriers in endoscopic examination and treatment of esophagus cancer]. Pol Merkur Lekarski (2007) 0.75
Functional Assessment of Synoptic Pathology Reporting for Ovarian Cancer. Pathobiology (2016) 0.75
[Mediastinal cyst in a patient on continuous ambulatory peritoneal dialysis successfully treated with video-assisted thoracic surgery (VATS)]. Pol Merkur Lekarski (2004) 0.75
[Syndromic surveillance in circumstances of bioterrorism threat--the essence, application abilities and superiority over a traditional epidemiological surveillance]. Pol Merkur Lekarski (2009) 0.75
Flexibility vs. robustness in cell cycle regulation of timing of M-phase entry in Xenopus laevis embryo cell-free extract. Int J Dev Biol (2016) 0.75
Morphological evaluation of the iliac and femoral arteries; possibilities and perspectives. Pol Przegl Chir (2014) 0.75
[Pseudoaneurysms after femoral arteries cannulations in hemodialysed patients--preliminary data]. Pol Merkur Lekarski (2004) 0.75
[Report of the activities of Warsaw-Lodz Branch of the Polish Society of Nephrology 1995-2001]. Pol Arch Med Wewn (2002) 0.75
[Pseudoaneurysm of arteriovenous fistula for haemodialysis]. Pol Merkur Lekarski (2002) 0.75
[Comparison of peritoneal transport of solutes and water during CAPD with glucose or amino acids solutions. Preliminary report]. Pol Merkur Lekarski (2002) 0.75
Experimental modeling of pulmonary barotrauma. Undersea Hyperb Med (2015) 0.75
[Effectiveness of subcutaneous and intravenous epoetin alpha in haemodialysed patients]. Pol Merkur Lekarski (2004) 0.75
[New method of biopsy of palatine tonsils and its role in the indication for tonsillectomy (preliminary report)]. Pol Merkur Lekarski (2005) 0.75
[Lupus vulgaris as a complication of pulmonary tuberculosis--case report]. Pol Merkur Lekarski (2009) 0.75
Evaluation of the NATO Disease Surveillance System by its users in Kosovo in 2008. Mil Med (2010) 0.75
Research on prevention and treatment of hemorrhagic fevers. Ann Agric Environ Med (2012) 0.75
Efficacy of automated peritoneal dialysis: from minimum to optimum. Pol Merkur Lekarski (2003) 0.75
[Ischaemic intestinal disease--still opened diagnostic clinical and pathomorphological problem]. Pol Merkur Lekarski (2004) 0.75
[Empirical therapy of peritonitis in peritoneal dialysis patients--it is reasonable to use a new therapeutic schedule?]. Pol Merkur Lekarski (2002) 0.75
Ephedrine-caffeine mixture in wet-cold stress. Pharmacol Rep (2006) 0.75
[Extended assessment of peritoneal transport kinetics of substances and water as an important element of integrated dialysis care]. Pol Merkur Lekarski (2004) 0.75
[Chlamydia pneumoniae antibodies and other atherosclerosis risk factors in haemodialysed patients. Preliminary report]. Pol Merkur Lekarski (2002) 0.75
Effect of isopropyl methylphosphonofluoridate (IMPF) poisoning on selected immunological parameters of angiogenesis. Ann Agric Environ Med (2014) 0.75
[Atherosclerotic or hypertensive nephropathy--case report]. Pol Merkur Lekarski (2004) 0.75
[Renal osteodystrophy as a cause of false positive result of whole body scintigraphy in a patient with differentiated thyroid cancer]. Pol Merkur Lekarski (2004) 0.75
[Spiral computed tomography angiography--advantages and limitations in nephrology and dialysotherapy]. Pol Merkur Lekarski (2002) 0.75
[Influence of parathormone level on the doses of human recombinant erythropoietin in haemodialysed patients]. Pol Merkur Lekarski (2002) 0.75
[Value of multidetector computed tomography and digital subtraction angiography in assessment of arterio-venous fistula for hemodialysis--own experiences]. Pol Merkur Lekarski (2004) 0.75
[The substances active against influenza virus. Possibilities and prospects of application]. Przegl Epidemiol (2009) 0.75
[Mood and illness-related stress in dialysed patients]. Pol Merkur Lekarski (2002) 0.75
[Microalbuminuria and atherosclerosis risk factors in potentially healthy men--preliminary data]. Pol Merkur Lekarski (2004) 0.75
[Plasmapheresis in a case of necessary discontinuation of cyclophosphamide in the treatment of severe lupus nephritis]. Pol Merkur Lekarski (2004) 0.75
[Pathomorphologic diagnostic guidelines for colon polyps]. Pol Merkur Lekarski (2007) 0.75
[Annular erythema as the skin manifestation of primary Sjögren's syndrome--case report]. Pol Merkur Lekarski (2010) 0.75